Heart Failure: Causes, Symptoms, and Management Strategies
Cardiac failure (HF) is a multifaceted clinical center described by the incapacity of a heart to sufficiently pump blood leading to inefficient perfusion of tissues. It has two main categories that are represented by ejection fraction: Heart Failure with Reduced Ejection Fraction (HFrEF), or Heart Failure with Preserved Ejection Fraction (HFpEF). The following review is a summary of research on the diverse causes, symptoms as well as management approaches involved in heart failure. Heart disorder comes about as a result of the following factors: coronary artery disease, hypertension, cardiomyopathy, valvular heart diseases, arrhythmias, and congenital heart defects the main symptoms include shortness of breath, weariness/tiredness, and swelling of the feet among others. Management strategies cover lifestyle modifications, medicines using treatment (e.g. diuretics, ACE inhibitors, beta-blockers), and further treatments like cardiac resynchronization therapy (CRT) consisting of implantable cardioverter defibrillators (ICDs) along with mechanical circulatory support (MCS); however, there is also heart transplant aside them.’ Future progression in genetic treatment gene therapy, as well as stem cell study, sounds promising over improving results obtained from HF treatment.
Authors
- Mohd Diya Masmoum
- Raheel Chaudhry
- Anfal Atif
- Imdad Ullah
- Hassan Ahmed (ORCID: https://orcid.org/0000-0002-8299-0129)
- Evelyn Pineiro Urra
- Lazaro H. Cabrera
- Arhum Mahmood
Institutions
- Alfaisal University (SA)
- Khyber Medical College (PK)
- Henry Ford Health System (US)
- Baylor College of Medicine (US)
- Universidad de Ciencias Médicas de Cienfuegos (CU)
- Dow University of Health Sciences (PK)
Publication Details
- Journal
- Journal of Advances in Medicine and Medical Research
- Published
- 2024-08-21
- DOI
- https://doi.org/10.9734/jammr/2024/v36i85551
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.40